Tupper Colleen (CIK 1862082) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-12). Recent activity: Sell COLL (26,679 shares), Buy COLL (32,734 shares), Sell COLL (11,861 shares), Buy COLL (26,421 shares), Sell COLL (25,142 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Sell | 26,679 | $1.2M |
| 2026-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Buy | 32,734 | $0 |
| 2026-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Sell | 11,861 | $554,502 |
| 2026-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Buy | 26,421 | $0 |
| 2025-11-07 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Sell | 25,142 | $1.0M |
| 2025-11-07 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Sell | 4,858 | $200,538 |
| 2025-03-24 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Sell | 1,206 | $36,180 |
| 2025-03-24 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Sell | 6,396 | $192,072 |
| 2025-03-18 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Sell | 977 | $29,310 |
| 2025-03-13 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Sell | 10,445 | $313,454 |
| 2025-03-10 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Sell | 1,949 | $58,470 |
| 2025-03-10 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Sell | 1,504 | $45,120 |
| 2025-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Buy | 51,768 | $0 |
| 2025-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Buy | 26,957 | $0 |
| 2025-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Sell | 8,109 | $247,487 |
| 2025-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Financial Officer | Sell | 22,317 | $681,115 |
Source: SEC Form 4 filings · as of 2026-02-12